Skip to main content
. 2022 Jan 25;12:1299. doi: 10.1038/s41598-022-05424-3

Table 1.

Comparison of clinical features between Clade 20B-T and Clade 20B-nonT.

N = 172 Clade 20B-T [B.1.1.284]
(N = 87)
*Clade 20B-nonT
(N = 85)
p value
Mean age (years old) 43.0 ± 17.6 45.6 ± 19.4 0.353
Sex (male/female) 57 / 30 56 / 29 1.000
Charlson Comorbidity Index (≧1) 29 (33.3%) 38 (44.7%) 0.159
Symptoms at admission
Cough 40 (46.0%) 44 (51.8%) 0.756
Dysosmia 12 (13.8%) 13 (15.3%) 1.000
Dysgeusia 10 (11.5%) 15 (17.6%) 0.388
Fever (≧ 37·5 °C) 51 (58.6%) 52 (61.2%) 0.432
Sepsis 0 1 (1.2%) 0.494
Acute respiratory distress syndrome 3 (3.4%) 8 (9.4%) 0.130
Treatment
Oxygen supplementation 13 (14.9%) 26 (30.6%) 0.011
Methylprednisolone treatment 10 (11.5%) 20 (23.5%) 0.045
Ventilator usage 2 (2.3%) 6 (7.1%) 0.166
Intensive care unit admission 4 (4.6%) 8 (9.4%) 0.245
Death 2 (2.3%) 2 (2.4%) 1.000

*Clade 20B-nonT includes various strains defined by Pangolin lineages; B.1.1.214, B.1.1.285, B.1.1.162, and B.1.1.29.